Bioter S.A. (BIOT) - Net Assets
Based on the latest financial reports, Bioter S.A. (BIOT) has net assets worth €-106.17 Million EUR (≈ $-124.12 Million USD) as of December 2022. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€85.09 Million ≈ $99.48 Million USD) and total liabilities (€191.26 Million ≈ $223.60 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BIOT asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-106.17 Million |
| % of Total Assets | -124.78% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Bioter S.A. - Net Assets Trend (2014–2022)
This chart illustrates how Bioter S.A.'s net assets have evolved over time, based on quarterly financial data. Also explore BIOT asset base for the complete picture of this company's asset base.
Annual Net Assets for Bioter S.A. (2014–2022)
The table below shows the annual net assets of Bioter S.A. from 2014 to 2022. For live valuation and market cap data, see Bioter S.A. stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | €-106.17 Million ≈ $-124.12 Million |
-10.03% |
| 2021-12-31 | €-96.49 Million ≈ $-112.81 Million |
-10.04% |
| 2020-12-31 | €-87.69 Million ≈ $-102.52 Million |
+6.36% |
| 2019-12-31 | €-93.64 Million ≈ $-109.48 Million |
-10.14% |
| 2018-12-31 | €-85.02 Million ≈ $-99.39 Million |
-19.08% |
| 2017-12-31 | €-71.39 Million ≈ $-83.47 Million |
-31.82% |
| 2016-12-31 | €-54.16 Million ≈ $-63.32 Million |
-52.84% |
| 2015-12-31 | €-35.44 Million ≈ $-41.43 Million |
-39.90% |
| 2014-12-31 | €-25.33 Million ≈ $-29.61 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Bioter S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 8063700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | €73.13 Million | % |
| Other Components | €415.00K | % |
| Total Equity | €-106.17 Million | 100.00% |
Bioter S.A. Competitors by Market Cap
The table below lists competitors of Bioter S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Pool Safe Inc
V:POOL
|
$3.45 Million |
|
Nicoccino Holding AB
ST:NICO
|
$3.45 Million |
|
Sodas Sodyum Sanayi AS
IS:SODSN
|
$3.46 Million |
|
Mawson Infrastructure Group Inc
NASDAQ:MIGI
|
$3.46 Million |
|
Abits Group Inc.
NASDAQ:ABTS
|
$3.45 Million |
|
Triple Point Social Housing REIT PLC
LSE:SOHO
|
$3.45 Million |
|
Franchise Brands PLC
LSE:FRAN
|
$3.44 Million |
|
H&T Group plc
LSE:HAT
|
$3.44 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bioter S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -96,493,000 to -106,170,000, a change of -9,677,000.
- Net loss of 9,677,000 reduced equity.
- Other factors decreased equity by 0.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-9.68 Million | -9.11% |
| Total Change | €- | % |
Book Value vs Market Value Analysis
This analysis compares Bioter S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | €-5.24 | €0.21 | x |
| 2021-12-31 | €-5.77 | €0.21 | x |
| 2022-12-31 | €-6.34 | €0.21 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bioter S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3840.08%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | -273.31% | 0.04x | 0.00x | €-10.95 Million |
| 2015 | 0.00% | -829.10% | 0.01x | 0.00x | €-6.59 Million |
| 2016 | 0.00% | -3325.77% | 0.01x | 0.00x | €-12.91 Million |
| 2017 | 0.00% | -9730.56% | 0.00x | 0.00x | €-10.38 Million |
| 2018 | 0.00% | -7229.38% | 0.00x | 0.00x | €-4.31 Million |
| 2019 | 0.00% | -3556.40% | 0.00x | 0.00x | €473.10K |
| 2020 | 0.00% | 2656.58% | 0.00x | 0.00x | €14.83 Million |
| 2021 | 0.00% | -3580.89% | 0.00x | 0.00x | €840.30K |
| 2022 | 0.00% | -3840.08% | 0.00x | 0.00x | €940.00K |
Industry Comparison
This section compares Bioter S.A.'s net assets metrics with peer companies in the Engineering & Construction industry.
Industry Context
- Industry: Engineering & Construction
- Average net assets among peers: $221,386,577
- Average return on equity (ROE) among peers: -16.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bioter S.A. (BIOT) | €-106.17 Million | 0.00% | N/A | $3.45 Million |
| Avax S.A (AVAX) | $64.19 Million | -66.93% | 22.91x | $451.64 Million |
| Domiki Kritis S.A. (DOMIK) | $7.43 Million | -0.24% | 1.81x | $37.95 Million |
| Ekter SA (EKTER) | $20.07 Million | 2.65% | 0.44x | $98.38 Million |
| Ellaktor S.A (ELLAKTOR) | $892.42 Million | -13.66% | 3.35x | $416.88 Million |
| GEK TERNA Holdings Real Estate Construction S.A (GEKTERNA) | $565.95 Million | -10.82% | 3.21x | $3.53 Billion |
| Intracom Constructions Societe Anonyme Technical and Steel Constructions (INKAT) | $60.31 Million | -38.39% | 6.06x | $1.03 Billion |
| Technical Olympic S.A (OLYMP) | $154.35 Million | -2.84% | 0.27x | $95.74 Million |
| Proodeftiki S.A. (PRD) | $6.36 Million | -4.94% | 2.41x | $8.07 Million |
About Bioter S.A.
Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects, such as offices, banks, bus stations, etc. The company was founded in 1961 and is based in Athens, Gree… Read more